ArticleThe FEBS journal2026
Unraveling the active site cover of coproheme decarboxylase from Listeria monocytogenes.
Article in The FEBS journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Coproheme decarboxylase (ChdC) is the terminal enzyme in Gram-positive heme b biosynthesis, an enzyme holding a special importance given its unique structure-function relationship and its necessity for bacterial survival. In the past, the enzyme has been shown to perform a double decarboxylation of two propionate groups on coproheme (Fe(III)-coproporphyrin III), subsequently converting it to heme b (iron-protoporphyrin IX). Notably, the active site of ChdCs is universally covered by a flexible loop. Its importance has not been fully studied but given its position it is assumed to provide steric hinderance for substrates or potential inhibitors to pass. This study aims to investigate its physiological role by introducing a histidine-to-alanine mutation located on the loop of ChdC from Listeria monocytogenes. Molecular dynamics simulation shows an increased flexibility of the structural element in the mutant. As a consequence, various kinetic studies at steady- and presteady-state conditions suggest coproheme binding and active site accessibility are improved. Using simulations and X-ray crystallography, we show evidence that the loop is originally stabilized by a hydrogen bond between S116 and the mutated H117. The higher accessibility also results in a higher susceptibility to damage from oxidative cosubstrates like H
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.